sleep apnea glp-1 drugs and Latest Insights on GLP-1 Therapy

Pembrolizumab as second-line therapy in patients with advanced hepatocellular carcinoma in KEYNOTE-240: a randomized, double-blind, phase III trial

Estradiol enhances the depolarizing action of GABA in developing hypothalamic neurons by increasing the magnitude of the calcium transient with each depolarization, increasing the number of neurons that respond to GABA A receptor activation with a calcium transient, and extending the developmental duration of depolarizing GABA action (162)

For T2DM, effective management of hyperglycemia and improved insulin sensitivity are critical for lowering rates of DNL and reducing hepatic fat

These medications significantly slow gastric emptying, prolonging the sensation of fullness after meals and reducing appetite through central mechanisms in the hypothalamus

Without human trials, clinicians cannot reliably determine appropriate dosing, long-term risks or whether benefits outweigh risks